Article
Tuberculosis and subsequent risk of lung cancer in Xuanwei, China.
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852, USA.
International Journal of Cancer (impact factor:
5.44).
11/2008;
124(5):1183-7.
DOI:10.1002/ijc.24042
pp.1183-7
Source: PubMed
-
Citations (0)
- Cited In (2)
-
Article: The study of Mycobacterium tuberculosis in Iranian patients with lung cancer
[show abstract] [hide abstract]
ABSTRACT: Backgrounds: Mycobacterium tuberculosis has the ability to invade type II alveolar epithelial cells. As a result, the associations between invasion of alveolar epithelial cells and pathogenesis of lung infection seem strong.. Objectives: The aim of this study was to evaluate the presence of Mycobacterium tuberculosis in patients with lung cancer.. Materials and methods: This cross-sectional study was performed on samples collected from 380 patients with lung cancer referred to two state-run hospitals in Mashhad, Iran. Microscopic and cultural methods were utilized to assess the presence of Mycobacterium tuberculosis in the patient's specimens.. Results: The subjects were included 252 (66.3%) males and 128 (33.7%) females. Based on cultural and microscopic methods, Mycobacterium tuberculosis infection was observed in twenty six (6.8%) of cases.. Conclusion: This study showed the high prevalence of Mycobacterium tuberculosis among the patients with lung cancer; therefore, it seems that continuous surveillance is essential to monitor the Mycobacterium tuberculosis in the patients with lung cancer..Jundishapur Journal of Microbiology 01/2013; 6(3). -
Article: Previous lung diseases and lung cancer risk: a systematic review and meta-analysis.
[show abstract] [hide abstract]
ABSTRACT: In order to review the epidemiologic evidence concerning previous lung diseases as risk factors for lung cancer, a meta-analysis and systematic review was conducted. Relevant studies were identified through MEDLINE searches. Using random effects models, summary effects of specific previous conditions were evaluated separately and combined. Stratified analyses were conducted based on smoking status, gender, control sources and continent. A previous history of COPD, chronic bronchitis or emphysema conferred relative risks (RR) of 2.22 (95% confidence interval (CI): 1.66, 2.97) (from 16 studies), 1.52 (95% CI: 1.25, 1.84) (from 23 studies) and 2.04 (95% CI: 1.72, 2.41) (from 20 studies), respectively, and for all these diseases combined 1.80 (95% CI: 1.60, 2.11) (from 39 studies). The RR of lung cancer for subjects with a previous history of pneumonia was 1.43 (95% CI: 1.22-1.68) (from 22 studies) and for subjects with a previous history of tuberculosis was 1.76 (95% CI=1.49, 2.08), (from 30 studies). Effects were attenuated when restricting analysis to never smokers only for COPD/emphysema/chronic bronchitis (RR=1.22, 0.97-1.53), however remained significant for pneumonia 1.36 (95% CI: 1.10, 1.69) (from 8 studies) and tuberculosis 1.90 (95% CI: 1.45, 2.50) (from 11 studies). Previous lung diseases are associated with an increased risk of lung cancer with the evidence among never smokers supporting a direct relationship between previous lung diseases and lung cancer.PLoS ONE 01/2011; 6(3):e17479. · 4.09 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
demographic characteristics
first 5 years
hazard ratios [HRs]
included lifetime medical history
increase lung cancer risk
increased lung cancer risk
indoor air pollution
lung cancer
lung cancer ascertained
Lung cancer mortality
lung disease
proportional hazards regression
retrospective cohort study
risk factor
rural Xuanwei County
smoky coal
smoky coal users
strong 5-9.9 years
subsequent lung cancer mortality
tobacco use